UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-04, Vol.17 (2), p.341-347

2014

Link zum Volltext

Verfügbarkeit prüfen

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study

Experimental hematology & oncology, 2023-07, Vol.12 (1), p.63-63

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer

Frontiers in medicine, 2022-06, Vol.9, p.830595-830595

2022

Link zum Volltext

Verfügbarkeit prüfen

Nouvelles AMMs : pemigatinib dans les cholangiocarcinomes avec fusion ou réarrangement de FGFR2

Bulletin du cancer, 2021-05, Vol.108 (5), p.446-447

2021

Link zum Volltext

Verfügbarkeit prüfen

Colorectal Cancer: Why Does Side Matter?

Drugs (New York, N.Y.), 2018-06, Vol.78 (8), p.789-798

2018

Link zum Volltext

Verfügbarkeit prüfen

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

The Journal of experimental medicine, 2015-02, Vol.212 (2), p.139-148

2015

Link zum Volltext

Verfügbarkeit prüfen

VEGFA-VEGFR Pathway Blockade Inhibits Tumor-induced Regulatory T-cell Proliferation in Colorectal Cancer

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (2), p.539-549

2013

Link zum Volltext

Verfügbarkeit prüfen

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

Drugs (New York, N.Y.), 2020-03, Vol.80 (4), p.401-415

2020

Link zum Volltext

Verfügbarkeit prüfen

Adénocarcinome œsogastrique – nouvelles cibles thérapeutiques

Bulletin du cancer, 2023-05, Vol.110 (5), p.560-569

2023

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint inhibitors and gastrointestinal immune-related adverse events

Current opinion in oncology, 2016-07, Vol.28 (4), p.264-268

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting EZH2 to overcome the resistance to immunotherapy in microsatellite stable colorectal cancer: Results from the CAIRE study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3599-3599

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Life Sciences & Biomedicine
(77)
Humans
(71)
Oncology
(38)
Cancer
(31)
Life Sciences
(29)
Male
(24)
Middle Aged
(24)
Female
(23)
Aged
(21)
Chemotherapy
(21)
Colorectal Cancer
(21)
Metastases
(20)
Metastasis
(20)
Adult
(19)
Gastroenterology & Hepatology
(17)
Patients
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Tumors
(13)
Prognosis
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge

Control of the immune response by pro-angiogenic factors

Colorectal cancer and immunity:what we know and perspectives

The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer

Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study

REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression

Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood

Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors

Furin Prodomain ppFurin Enhances Ca2+ Entry Through Orai and TRPC6 Channels’ Activation in Breast Cancer Cells

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study

Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer

Nouvelles AMMs : pemigatinib dans les cholangiocarcinomes avec fusion ou réarrangement de FGFR2

Colorectal Cancer: Why Does Side Matter?

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

VEGFA-VEGFR Pathway Blockade Inhibits Tumor-induced Regulatory T-cell Proliferation in Colorectal Cancer

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

Adénocarcinome œsogastrique – nouvelles cibles thérapeutiques

Checkpoint inhibitors and gastrointestinal immune-related adverse events

Targeting EZH2 to overcome the resistance to immunotherapy in microsatellite stable colorectal cancer: Results from the CAIRE study

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Suchergebnisse filtern